Bill
Bill > SB5981
summary
Introduced
01/12/2026
01/12/2026
In Committee
03/02/2026
03/02/2026
Crossed Over
02/13/2026
02/13/2026
Passed
03/25/2026
03/25/2026
Dead
Signed/Enacted/Adopted
03/25/2026
03/25/2026
Introduced Session
2025-2026 Regular Session
Bill Summary
AN ACT Relating to protecting the integrity of the 340B drug 2 pricing program; amending RCW 43.71C.010, 43.71C.050, 43.71C.090, and 3 43.71C.100; adding new sections to chapter 43.71C RCW; adding a new 4 chapter to Title 69 RCW; and prescribing penalties. 5
AI Summary
This bill aims to protect the integrity of the federal 340B drug pricing program, which provides discounted outpatient medications to eligible healthcare providers serving low-income and uninsured populations, by prohibiting drug manufacturers from restricting how these providers access and dispense these drugs through contract pharmacies, and by requiring covered entities and manufacturers to report detailed information about their participation in the program to the state, with penalties for non-compliance and a new filing fee to support the state's data collection and reporting efforts.
Committee Categories
Budget and Finance, Health and Social Services
Sponsors (13)
Annette Cleveland (D)*,
Emily Alvarado (D),
Jessica Bateman (D),
Mike Chapman (D),
Manka Dhingra (D),
Noel Frame (D),
Paul Harris (R),
Bob Hasegawa (D),
Marko Liias (D),
Jamie Pedersen (D),
Rebecca Saldaña (D),
Vandana Slatter (D),
Javier Valdez (D),
Last Action
Effective date 6/11/2026. (on 03/25/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...